Significant geographic, demographic variation in use of anti-VEGF agents for wet AMD
- Posted on: Jan 5 2018
- Leave a response
Investigators evaluated demographic and geographic patterns in the use of ranibizumab versus bevacizumab for newly diagnosed neovascular AMD among Medicare beneficiaries in the US.
Source: AAO
Posted in: Uncategorized
